Singapore Wants You!
Singapore Wants You!
“The future-friendly city-state has an offer bioscientists can’t refuse: unrestricted research, top-notch equipment, and limitless funds. (Just leave your chewing gum at home.)”
Biotech's Longer Convalescence
Biotech’s Longer Convalescence
“The biotech sector has fallen, and it doesn’t seem able to get up. “
China: how to seize "commanding point" of biotechnology
China: how to seize “commanding point” of biotechnology
“China’s capital investment in the scientific research of life science is far from enough, and the government should create fine environment for the development of biotechnology industry, and mobilize all forces in the society to develop biotechnology and industry…”
Stem-Cell Cash on a Winding Road
Stem-Cell Cash on a Winding Road
They may not be investing in the companies themselves, but venture capitalists haven’t completely abandoned stem-cell work. Instead, they’re contributing through efforts like the California Stem Cell Initiative…
Financial Snapshot For June 2004
Financial Snapshot For June 2004
Lackluster Performance
12
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments